OBJECTIVE: Patients with sleep apnea syndrome have an increased risk of cardiovascular events and frequently show a nondipper pattern (blunted nocturnal decline <10%) of systolic blood pressure. We investigated neurohumoral activation and risk factors in relation to nocturnal blood pressure dipping pattern and sleep apnea syndrome. METHODS: We conducted sleep polysomnography and ambulatory blood pressure monitoring and measured high-sensitivity C-reactive protein, tissue-type plasminogen activator inhibitor-1, and neurohumoral factors in 121 outpatients with suspected sleep apnea syndrome who were classified into four groups on the basis of the presence or the absence of dipping/nondipping and sleep apnea syndrome. RESULTS: Nondippers with sleep apnea syndrome had higher high-sensitivity C-reactive protein (overall P < 0.001), plasminogen activator inhibitor-1 (overall P = 0.004), and aldosterone levels (overall P = 0.010) than any of the other three groups. After adjustment for significant covariates such as age, sex, body mass index, waist circumference, smoking, alcohol drinking, aspirin use, presence of diabetes, and insulin, nondippers with sleep apnea syndrome still had a higher high-sensitivity C-reactive protein level than nondippers without sleep apnea syndrome (geometric mean: 1.47 vs. 0.37 mg/l, P = 0.001). In multiple linear regression analysis controlling for confounding factors related with sleep apnea syndrome, high-sensitivity C-reactive protein was significantly correlated with 3% oxygen desaturation index (P = 0.047). Plasminogen activator inhibitor-1 level was also highest in the nondippers with sleep apnea syndrome but not independent of obesity. Plasminogen activator inhibitor-1 level correlated with insulin (r = 0.32, P = 0.002) and high-sensitivity C-reactive protein levels (r = 0.26, P = 0.005). CONCLUSION: Nondipper status was associated with an increased high-sensitivity C-reactive protein level in patients who also had sleep apnea syndrome but not in those who did not. High-sensitivity C-reactive protein level was closely affected by the desaturation level. Plasminogen activator inhibitor-1 level is also increased in nondippers with sleep apnea syndrome and is related to insulin and high-sensitivity C-reactive protein levels.
OBJECTIVE:Patients with sleep apnea syndrome have an increased risk of cardiovascular events and frequently show a nondipper pattern (blunted nocturnal decline <10%) of systolic blood pressure. We investigated neurohumoral activation and risk factors in relation to nocturnal blood pressure dipping pattern and sleep apnea syndrome. METHODS: We conducted sleep polysomnography and ambulatory blood pressure monitoring and measured high-sensitivity C-reactive protein, tissue-type plasminogen activator inhibitor-1, and neurohumoral factors in 121 outpatients with suspected sleep apnea syndrome who were classified into four groups on the basis of the presence or the absence of dipping/nondipping and sleep apnea syndrome. RESULTS: Nondippers with sleep apnea syndrome had higher high-sensitivity C-reactive protein (overall P < 0.001), plasminogen activator inhibitor-1 (overall P = 0.004), and aldosterone levels (overall P = 0.010) than any of the other three groups. After adjustment for significant covariates such as age, sex, body mass index, waist circumference, smoking, alcohol drinking, aspirin use, presence of diabetes, and insulin, nondippers with sleep apnea syndrome still had a higher high-sensitivity C-reactive protein level than nondippers without sleep apnea syndrome (geometric mean: 1.47 vs. 0.37 mg/l, P = 0.001). In multiple linear regression analysis controlling for confounding factors related with sleep apnea syndrome, high-sensitivity C-reactive protein was significantly correlated with 3% oxygen desaturation index (P = 0.047). Plasminogen activator inhibitor-1 level was also highest in the nondippers with sleep apnea syndrome but not independent of obesity. Plasminogen activator inhibitor-1 level correlated with insulin (r = 0.32, P = 0.002) and high-sensitivity C-reactive protein levels (r = 0.26, P = 0.005). CONCLUSION: Nondipper status was associated with an increased high-sensitivity C-reactive protein level in patients who also had sleep apnea syndrome but not in those who did not. High-sensitivity C-reactive protein level was closely affected by the desaturation level. Plasminogen activator inhibitor-1 level is also increased in nondippers with sleep apnea syndrome and is related to insulin and high-sensitivity C-reactive protein levels.
Authors: F J Nieto; T B Young; B K Lind; E Shahar; J M Samet; S Redline; R B D'Agostino; A B Newman; M D Lebowitz; T G Pickering Journal: JAMA Date: 2000-04-12 Impact factor: 56.272
Authors: Abu S M Shamsuzzaman; Mikolaj Winnicki; Paola Lanfranchi; Robert Wolk; Tomas Kara; Valentina Accurso; Virend K Somers Journal: Circulation Date: 2002-05-28 Impact factor: 29.690
Authors: Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; José S Loredo; Joel E Dimsdale Journal: Sleep Date: 2010-03 Impact factor: 5.849
Authors: Euphemia G Daskalopoulou; Christos Liavvas; Christos T Nakas; Emmanuel G Vlachogiannis; Demosthenes Bouros; Nicholas V Dombros Journal: Sleep Breath Date: 2010-09-25 Impact factor: 2.816
Authors: Zehra Tosur; David Green; Peter John De Chavez; Kristen L Knutson; Jeffrey J Goldberger; Phyllis Zee; Kiang Liu; Kwang-Youn Kim; Mercedes R Carnethon Journal: Sleep Med Date: 2014-04-30 Impact factor: 3.492
Authors: I Mateo-Gavira; F J Vílchez-López; M V García-Palacios; F Carral-San Laureano; F M Visiedo-García; M Aguilar-Diosdado Journal: J Hum Hypertens Date: 2016-08-18 Impact factor: 3.012
Authors: Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; Tanya Wolfson; Anthony C Gamst; José S Loredo; Joel E Dimsdale Journal: Sleep Med Date: 2012-10-01 Impact factor: 3.492
Authors: Wendy M Troxel; Daniel J Buysse; Martica Hall; Thomas W Kamarck; Patrick J Strollo; Jane F Owens; Steven E Reis; Karen A Matthews Journal: J Hypertens Date: 2010-02 Impact factor: 4.844